Profil
Thomas E.
Jenkins is the founder of Elysium Therapeutics, Inc., founded in 2013, where the title held is Chief Scientific Officer.
Former job includes Chief Scientific Officer & Vice President-Research at Signature Therapeutics, Inc. Education history includes a doctorate from Stanford University and an undergraduate degree from the University of Akron.
Postes actifs de Thomas Jenkins
| Sociétés | Poste | Début |
|---|---|---|
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Fondateur | 01/01/2013 |
Anciens postes connus de Thomas Jenkins
| Sociétés | Poste | Fin |
|---|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Directeur Technique/Scientifique/R&D | - |
Formation de Thomas Jenkins
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Akron
University of Akron Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
















